Using a pharmacological inhibitor of EGFR, we succeeded in delaying pulmonary metastasis in nude mice injected with these variant cells and promoting their survival, which suggests that targeting the EGFR/PI3K/Akt pathway holds potential in preventing metastasis of human ACC. The gene discussed is EGFR; the disease is adrenal cortex carcinoma.